We are live on ! Find out more
JE

JMAC Enterprises Portfolio holdings

AUM $522M
1-Year Est. Return 15.34%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+15.34%
3 Year Est. Return
+52.85%
5 Year Est. Return
10 Year Est. Return
AUM
$364M
AUM Growth
+$7.42M
Cap. Flow
-$21.6M
Cap. Flow %
-5.94%
Top 10 Hldgs %
37.94%
Holding
180
New
8
Increased
28
Reduced
112
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 10.67%
2 Technology 4.79%
3 Consumer Staples 3.26%
4 Financials 2.07%
5 Consumer Discretionary 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
126
IBM
IBM
$200B
$437K 0.12%
3,100
-944
-23% -$130K
ENOR icon
127
iShares MSCI Norway ETF
ENOR
$78.1M
$426K 0.12%
17,347
-28,226
-62% -$668K
MDT icon
128
Medtronic
MDT
$106B
$405K 0.11%
5,213
-2,000
-28% -$162K
USB icon
129
US Bancorp
USB
$98.4B
$387K 0.11%
8,867
-5,772
-39% -$247K
DOW icon
130
Dow Inc
DOW
$21.6B
$384K 0.11%
7,613
-5,897
-44% -$288K
CP icon
131
Canadian Pacific Kansas City
CP
$83.2B
$376K 0.1%
5,036
-6
-0.1% -$451
TXN icon
132
Texas Instruments
TXN
$258B
$363K 0.1%
2,200
-105
-5% -$17.5K
KR icon
133
Kroger
KR
$36B
$361K 0.1%
8,100
ABT icon
134
Abbott
ABT
$175B
$360K 0.1%
3,279
ETR icon
135
Entergy
ETR
$52.8B
$352K 0.1%
6,264
CPB icon
136
Campbell Soup
CPB
$6.58B
$350K 0.1%
6,171
-700
-10% -$36.7K
SCHP icon
137
Schwab US TIPS ETF
SCHP
$16.4B
$334K 0.09%
12,914
-10,812
-46% -$283K
AZN icon
138
AstraZeneca
AZN
$262B
$323K 0.09%
2,379
LYB icon
139
LyondellBasell Industries
LYB
$19.1B
$316K 0.09%
3,800
-1,200
-24% -$98.3K
NVO
140
Novo Nordisk
NVO
$223B
$315K 0.09%
4,656
GPC icon
141
Genuine Parts
GPC
$17.2B
$312K 0.09%
1,800
-3,100
-63% -$539K
IJS icon
142
iShares S&P Small-Cap 600 Value ETF
IJS
$8.15B
$310K 0.09%
3,399
CAT icon
143
Caterpillar
CAT
$405B
$308K 0.08%
1,285
-294
-19% -$64K
ADM icon
144
Archer Daniels Midland
ADM
$41.4B
$304K 0.08%
3,273
-9
-0.3% -$831
UNH icon
145
UnitedHealth
UNH
$387B
$302K 0.08%
570
-4
-0.7% -$2.12K
ACN icon
146
Accenture
ACN
$87.9B
$282K 0.08%
1,058
-3
-0.3% -$830
PSX icon
147
Phillips 66
PSX
$82.9B
$274K 0.08%
2,635
-800
-23% -$81.8K
SO icon
148
Southern Company
SO
$107B
$273K 0.08%
3,824
+3
+0.1% +$201
MTB icon
149
M&T Bank
MTB
$36.1B
$261K 0.07%
1,800
MMM icon
150
3M
MMM
$83.4B
$259K 0.07%
2,587
-2,033
-44% -$207K

Similar funds

JMAC Enterprises's Q4 2022 Portfolio in Review

As of Q4 2022, JMAC Enterprises held 180 positions worth $364M, up 2.1% from $356M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

JMAC Enterprises withdrew a net $21.6M in Q4 2022, closing 6 positions and reducing 112 holdings. Its most notable exit was Gilead Sciences, an estimated $620K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, JMAC Enterprises opened a new position in Blackrock worth $259K.

  • JMAC Enterprises's largest Q4 2022 buy was Blackrock: 365 shares worth $259K.
  • JMAC Enterprises added most to Air Products & Chemicals in Q4 2022, an estimated $217K increase.
  • JMAC Enterprises's biggest Q4 2022 reduction was State Street Materials Select Sector SPDR ETF, cutting an estimated $1.56M.
  • JMAC Enterprises fully exited Gilead Sciences in Q4 2022, selling an estimated $620K.
  • JMAC Enterprises's ten largest holdings make up 38% of its $364M portfolio in Q4 2022.
  • JMAC Enterprises opened 8 new positions and closed 6 in Q4 2022.
  • JMAC Enterprises's portfolio value rose 2.1% quarter-over-quarter to $364M.

Based on JMAC Enterprises's 13F filing for Q4 2022, filed 23 Jan 2023.